GlassScriptPhysician profile
Jake Weiss
NPI 1760121206
$2,297.69
in general payments reported to CMS, 2019-2025
15 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $385 · 2023: $707 · 2024: $931 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.61 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $626.22 | 2022-2025 | Cequa, Xelpros |
| Alcon Vision LLC | $298.51 | 2023-2024 | Total30, Rocklatan |
| Horizon Therapeutics Plc | $266.81 | 2022-2023 | Tepezza |
| Bausch & Lomb Americas INC. | $239.40 | 2024-2025 | Miebo, Vyzulta, Xiidra |
| Oyster Point Pharma, INC. | $212.08 | 2023-2024 | Tyrvaya |
| Abbvie INC. | $195.02 | 2023-2025 | Vuity, Alphagan P, Lumigan |
| Tarsus Pharmaceuticals, INC. | $124.80 | 2024 | Xdemvy |
| Coopervision INC. | $109.62 | 2024 | Misight Contact Lens |
| Sight Sciences, INC. | $102.99 | 2023 | Omni Surgical System |
| Harrow Eye, LLC | $24.20 | 2025 | Vevye |
| Mallinckrodt Hospital Products INC. | $23.18 | 2022 | |
| Amgen INC. | $21.97 | 2025 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $19.14 | 2025 | |
| Dompe US, INC. | $17.34 | 2025 | Oxervate |
| Apellis Pharmaceuticals, INC. | $16.41 | 2025 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jake Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.